-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, T9idHjHxI9Xa1vNQDxre0Hxou3c/dqijL8E1wQkJYehgkFcjHcvgZHBKoeBHRZll w8HnumE5hbHaeIDk6v3Qtg== 0000014272-04-000068.txt : 20040304 0000014272-04-000068.hdr.sgml : 20040304 20040304172439 ACCESSION NUMBER: 0000014272-04-000068 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040302 FILED AS OF DATE: 20040304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BONFIELD ANDREW R J CENTRAL INDEX KEY: 0001199292 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 04649597 BUSINESS ADDRESS: STREET 1: C/O BRISTOL MYERS SQUIBB CO STREET 2: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10164 MAIL ADDRESS: STREET 1: C/O BRISTOL MYERS SQUIBB CO STREET 2: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10164 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 4 1 bon220.xml X0201 4 2004-03-02 0 0000014272 BRISTOL MYERS SQUIBB CO (BMY) 0001199292 BONFIELD ANDREW R J 345 PARK AVENUE NEW YORK NY 10154 0 1 0 0 SVP & CFO Common Stock, $0.10 par value 2004-03-02 4 A 0 18889 0 A 153889.00 D Common Stock, $0.10 par value 320.62 I By BMY Savings & Investment Program Option (right to buy) 28.11 2004-03-02 4 A 0 113333 0 A 2014-03-01 Common Stock, $0.10 par value 113333 113333 D Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Based on a plan statement as of the end of the most recent fiscal quarter. Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. By: /s/ Sandra Leung, Attorney-in-Fact 2004-03-04 -----END PRIVACY-ENHANCED MESSAGE-----